Epclusa is a brand name of sofosbuvir/velpatasvir. An authorized generic version of Epclusa has been approved. An Authorized Generic is a prescription drug that is produced by a brand company under a New Drug Application (NDA) and marketed as a generic under a private label. It is identical to the branded product in appearance and has exactly the same inactive ingredients.

Sofosbuvir and velpatasvir is a combination antiviral medicine used to treat chronic hepatitis C in adults and children at least 3 years old.

List of authorized generic versions:

• Velpatasvir and Sofosbuvir ORAL TABLET, FILM COATED 400; 100 mg/1; mg Asegua Therapeutics LLC NDC Code: 726262701